Voyager Therapeutics, Inc.
News
ClariVest Asset Management LLC Acquires 2,699 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR)
Ticker Report ClariVest Asset Management LLC boosted its holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR - Free Report) by 2.7% in the second quarter, HoldingsChannel reports. The firm owned 102,822 shares of...\n more…
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Ticker Report Voyager Therapeutics, Inc. (NASDAQ:VYGR - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the seven brokerages that are currently covering the firm, Marketbeat reports...\n more…
Ritholtz Wealth Management Reduces Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR)
Ticker Report Ritholtz Wealth Management trimmed its stake in shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR - Free Report) by 24.9% during the 2nd quarter, according to the company in its most recent 13F...\n more…
Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
Globe Newswire Voyager to receive upfront consideration of $15 million and is eligible to receive up to $305 million in potential associated milestone payments and royaltiesLEXINGTON, Mass., Sept. 05, 2024 (GLOBE...\n more…
Voyager Therapeutics (NASDAQ:VYGR) Share Price Passes Below Fifty Day Moving Average of $7.70
Zolmax Voyager Therapeutics, Inc. (NASDAQ:VYGR - Get Free Report) shares passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $7.70 and traded as low...\n more…
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire LEXINGTON, Mass., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, has entered into an employment...\n more…